ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Radiation Improves Survival In Advanced Prostate Cancer

June 25, 2010

New Phone Number For Customer Service For The Cancer Letter

February 6, 1998

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997